Protein kinase inhibitors as a therapeutic modality.

  title={Protein kinase inhibitors as a therapeutic modality.},
  author={Alexander Levitzki},
  journal={Accounts of chemical research},
  volume={36 6},
Most of the signal transduction pathways are mediated by protein kinases regulating every aspect of cell function. Mutations which deregulate their expression or their function or both result in cancers. Therefore, protein kinase inhibitors has become the focus of development of new therapies for cancer. Almost all 120 protein tyrosine kinases are involved in signaling, whereas only a handful of Ser/Thr kinases are involved. Thus, most of the effort is directed toward the development of… CONTINUE READING
26 Citations
88 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 26 extracted citations


Publications referenced by this paper.
Showing 1-10 of 88 references

Catechol bioisosteres substrate competitive inhibitors of IGF - 1 R

  • G. Blum, A. Gazit, A. Levitzki
  • 2003

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266

  • R. Catlett-Falcone, T H.Landowski, +9 authors R. Jove
  • Cancer Cell 2002,
  • 2002

Discovery of a novel

  • J. F. Lyons, S Wilhelm, B. Hibner, G. Bollag
  • Nature
  • 2002

Perspectives on the development of a molecularly targeted agent

  • J. DrukerB.
  • Cancer Cell
  • 2002

Similar Papers

Loading similar papers…